“…It was proposed by Dubois, Slachevsky, Litvan & Pillon (2000) as a short bedside cognitive battery for patients with frontal lobe dysfunction. Two Brazilian versions were proposed, one by Beato, Nitrini, Formigoni & Caramelli (2007) with preliminary data for the administration in healthy elderly patients and subsequent norms (Beato et al, 2012) and the other, slightly different, exposed in a dissertation, in which the validity and normative values of three screening tests including the FAB were developed in a representative sample of a Brazilian city (Moura, 2008).The test has been used in different clinical populations that usually present frontal lobe dysfunction, such as frontotemporal dementia, Parkinson's disease dementia, corticobasal degeneration, progressive supranuclear palsy, and multiple system atrophy (Dubois et al, 2000). Some studies have proposed its use for the differential diagnosis of Alzheimer's disease (AD) from frontotemporal dementia and found good (Slachevsky et al, 2004); however, these findings were inconsistent (Castiglione et al, 2008).…”